215 related articles for article (PubMed ID: 10336919)
1. Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study.
Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Giubilato A; Paterna S
Heart; 1999 Jun; 81(6):606-11. PubMed ID: 10336919
[TBL] [Abstract][Full Text] [Related]
2. Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study.
Di Pasquale P; Bucca V; Scalzo S; Paterna S
Cardiovasc Drugs Ther; 1998 May; 12(2):211-6. PubMed ID: 9652880
[TBL] [Abstract][Full Text] [Related]
3. Captopril plus losartan in early post-infarction. Neurohormonal effects: a pilot study.
Di Pasquale P; Cannizzaro S; Longo AM; Maringhini G; Iachininoto R; Paterna S
G Ital Cardiol; 1997 Dec; 27(12):1256-63. PubMed ID: 9470059
[TBL] [Abstract][Full Text] [Related]
4. Additional beneficial effects of canrenoate in patients with anterior myocardial infarction on ACE-inhibitor treatment. A pilot study.
Di Pasquale P; Cannizzaro S; Giubilato A; Vitrano MG; Scandurra A; Giambanco F; Saccone G; Sarullo FM; Paterna S
Ital Heart J; 2001 Feb; 2(2):121-9. PubMed ID: 11256540
[TBL] [Abstract][Full Text] [Related]
5. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
[TBL] [Abstract][Full Text] [Related]
6. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
Dickstein K; Kjekshus J;
Lancet; 2002 Sep; 360(9335):752-60. PubMed ID: 12241832
[TBL] [Abstract][Full Text] [Related]
7. The combination ace-inhibitors plus canreonate in patients with anterior myocardial infarction: safety and tolerability study.
Di Pasquale P; Alessi V; Barberi O; Scandurra A; Bucca V; Maringhini G; Scalzo S; Paterna S
Int J Cardiol; 2001 Feb; 77(2-3):119-27; discussion 128-9. PubMed ID: 11182173
[TBL] [Abstract][Full Text] [Related]
8. Early treatment with captopril after acute myocardial infarction.
Ray SG; Pye M; Oldroyd KG; Christie J; Connelly DT; Northridge DB; Ford I; Morton JJ; Dargie HJ; Cobbe SM
Br Heart J; 1993 Mar; 69(3):215-22. PubMed ID: 8461219
[TBL] [Abstract][Full Text] [Related]
9. A comparison of intervention with losartan or captopril in acute myocardial infarction.
Spinar J; Vitovec J; Spinarova L; Pluhacek L; Fischerova B; Toman J
Eur J Heart Fail; 2000 Mar; 2(1):91-100. PubMed ID: 10742708
[TBL] [Abstract][Full Text] [Related]
10. First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction.
Spinar J; Vitovec J; Pluhacek L; Spinarova L; Fischerova B; Toman J
Int J Cardiol; 2000 Sep; 75(2-3):197-204. PubMed ID: 11077134
[TBL] [Abstract][Full Text] [Related]
11. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
[TBL] [Abstract][Full Text] [Related]
12. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
13. [Is the reduction of the plasma levels of endothelin in the acute and sub-acute stage of myocardial infarct one of the beneficial effects of early treatment with ace inhibitors?].
Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Longo AM; Alessi V; D'Amato M; Manusia F; Magatti MF
G Ital Cardiol; 1996 Jun; 26(6):673-80. PubMed ID: 8803588
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
Zhu B; Sun Y; Sievers RE; Browne AE; Pulukurthy S; Sudhir K; Lee RJ; Chou TM; Chatterjee K; Parmley WW
J Am Coll Cardiol; 2000 Mar; 35(3):787-95. PubMed ID: 10716484
[TBL] [Abstract][Full Text] [Related]
15. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
Møller JE; Dahlström U; Gøtzsche O; Lahiri A; Skagen K; Andersen GS; Egstrup K;
Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
Dickstein K; Kjekshus J
Am J Cardiol; 1999 Feb; 83(4):477-81. PubMed ID: 10073846
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction?
Doggrell SA
Expert Opin Pharmacother; 2003 Mar; 4(3):407-9. PubMed ID: 12614193
[TBL] [Abstract][Full Text] [Related]
19. Survival after myocardial infarction in rats: captopril versus losartan.
Milavetz JJ; Raya TE; Johnson CS; Morkin E; Goldman S
J Am Coll Cardiol; 1996 Mar; 27(3):714-9. PubMed ID: 8606287
[TBL] [Abstract][Full Text] [Related]
20. ACE-inhibition plus mineralocorticoid antagonism versus ACE-inhibition alone in patients with anterior myocardial infarction.
Di Pasquale P; Cannizzaro S; Scandurra A; Giubilato A; Scalzo S; Paterna S
Cardiovasc Drugs Ther; 2001 Jul; 15(4):309-14. PubMed ID: 11800414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
